MELA CARE · Melasma Integrated Protocol
Built as one protocol. Designed to work together.
Skin conditions rarely involve a single biological pathway. That is why we develop companion therapies designed to support one another within a clinical system.
Correct
Renew
Repair
Protect
Clinical support system
MELA CARE
A science-driven clinical support system designed to complement modern melasma management through four interconnected therapeutic pillars.
- Active Depigmentation
- Barrier Recovery
- Gentle Resurfacing
- Advanced Photoprotection
Companion therapies
Four products, one clinical system.
Active Depigmentation Companion Therapy. Targets excessive melanogenesis through multiple biological pathways involved in pigmentation.
Gentle Resurfacing Companion Therapy. Supports controlled epidermal renewal and texture refinement with improved tolerability throughout melasma management.
Recovery Companion Moisturizer. Supports barrier resilience, skin comfort, and treatment tolerance during active depigmentation therapy.
Advanced 4D Photoprotection Companion Sunscreen. Provides daily protection against the light spectrum associated with melasma persistence and recurrence.
- Key technology
- AminoClarity™ Technology
- Core components
- Nanoencapsulated Cysteamine · N-Acetyl Cysteine · Ergothioneine
- Best for
- Epidermal melasma · Recurrent pigmentation · Long-term depigmentation protocols
- Key technology
- Trinewal™ Complex
- Core components
- Supramolecular Retinal · Hydroxypinacolone Retinoate (HPR) · Bakuchiol
- Best for
- Rough texture · Dull skin · Renewal support
- Key technology
- AdapthINC™ Technology
- Core components
- Panthenol 10% · Lactobacillus Metabiotics · Beta-Glucan · Ectoin · Glycosaminoglycans
- Best for
- Irritated skin · Barrier impairment · Active treatment support
- Key technology
- AdapthINC™ Technology
- Core components
- Zinc Oxide · N3 Titanium Dioxide · Iron Oxides · Ectoin
- Best for
- Melasma-prone skin · Visible light exposure · Tropical climates
Because successful skin management depends on
Empat fase yang terkoordinasi
Setiap produk punya peran yang jelas.
Repair
Glucothenol 10
Memulihkan barrier dan mendukung toleransi.
AdapthINC · Metabiotic Barrier
Rutinitas AM & PM
From morning to night.
Empat produk yang dirancang bersama dokter kulit untuk saling mendukung, dari pagi sampai malam.
Pagi (AM)
- Bersihkan dan keringkan kulit
CysteaProKontrol pigmen
Glucothenol 10 Pagi & malamDukungan barrier
SunShield 4DXProteksi cahaya
Malam (PM)
- Bersihkan dan keringkan kulit
RetinPro 3Pembaruan & clearance- Glucothenol 10 Pagi & malamDukungan barrier
Urutan dan frekuensi disesuaikan oleh dokter menurut toleransi. Ini bukan aturan universal.
Perkiraan timeline
Dua belas minggu, tiga fase.
Perkiraan umum dari protokol melasma. Dokter menyesuaikan urutan dan frekuensinya dengan toleransi kulit Anda.
- Minggu 0–4Inisiasi
Pengenalan bertahap, fokus pada toleransi dan kenyamanan barrier.
- Minggu 4–12Intensifikasi
Protokol penuh; perbaikan biasanya terlihat pada rentang ini.
- BerkelanjutanMaintenance
Proteksi dan dukungan barrier untuk menurunkan risiko kambuh.
Clinical evidence
Diukur, bukan diasumsikan.
- −71Melanin Index
12 minggu · n=20 · instrumental
- −33%TEWL
12 minggu · n=20 · perbaikan barrier
- −1,89mMASI
12 minggu · n=20 · perbaikan klinis
Evaluasi produk tunggal (CysteaPro) 12 minggu (n=20), pengukuran instrumental.
Lihat evidenceToleransi & panduan keamanan
Pelan-pelan, tapi konsisten.
- Perkenalkan langkah aktif secara bertahap untuk mendukung toleransi.
- Pertahankan dukungan barrier sepanjang regimen.
- Proteksi cahaya harian penting untuk menurunkan kekambuhan.
- Sesuaikan dengan dokter bila terjadi iritasi.